Cerus Corp. (NASDAQ:CERS) shares were down 1.5% on Thursday . The stock traded as low as $6.69 and last traded at $6.70, with a volume of 540,917 shares. The stock had previously closed at $6.80.

Several research analysts have weighed in on CERS shares. Cantor Fitzgerald reaffirmed a “buy” rating and set a $9.00 price target on shares of Cerus Corp. in a research report on Sunday, July 31st. FBR & Co reaffirmed an “outperform” rating and set a $10.00 price target on shares of Cerus Corp. in a research report on Thursday, August 11th. Zacks Investment Research lowered Cerus Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday, August 9th. BTIG Research reaffirmed a “buy” rating and set a $10.00 price target (up previously from $8.00) on shares of Cerus Corp. in a research report on Friday, April 22nd. Finally, Robert W. Baird reaffirmed an “outperform” rating and set a $9.00 price target on shares of Cerus Corp. in a research report on Wednesday, June 22nd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the stock. Cerus Corp. has an average rating of “Buy” and a consensus price target of $9.10.

The firm has a 50-day moving average price of $6.69 and a 200-day moving average price of $6.00. The firm’s market cap is $688.15 million.

Cerus Corp. (NASDAQ:CERS) last released its earnings results on Thursday, August 4th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.01. During the same period in the prior year, the company earned ($0.17) earnings per share. The company earned $9.25 million during the quarter, compared to analyst estimates of $8.88 million. Cerus Corp.’s revenue for the quarter was up 4.8% compared to the same quarter last year. On average, equities research analysts anticipate that Cerus Corp. will post ($0.68) earnings per share for the current fiscal year.

A number of large investors have added to or reduced their stakes in the company. Rail Splitter Capital Management LLC boosted its stake in Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock valued at $5,263,000 after buying an additional 132,970 shares in the last quarter. Stephens Inc. AR boosted its stake in Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock valued at $7,032,000 after buying an additional 113,238 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its stake in Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock valued at $30,979,000 after buying an additional 1,007,430 shares in the last quarter.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.